CEO Kwon-seon Lee Increases Stake to 34.65% via Open Market Purchases
- CEO Kwon-seon Lee acquired an additional 12,403 common shares through open market purchases on May 15 and 18, 2026.
- Acquisition prices were 7,763 KRW and 6,568 KRW per share, respectively, averaging 7,270 KRW.
- As a result, Lee's stake increased from 34.52% to 34.65%, a rise of 0.13 percentage points.
- Total outstanding shares remain unchanged at 9,341,201 shares.
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
- Company: Cell Bio Human Tech (318160)
- Submission: Kwon-seon Lee
- Receipt: 05-20-2026